Developer docs
API playgroundTry for free, no card

Search company profiles

IPMD, Inc.

Full company profile

uuid003vxq8

Namestring
IPMD, Inc.
Legal namestring
IPMD, Inc.
Websiteurl
ipmdinc.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

IPMD, Inc. is a privately held emotional AI company founded in 2016 and headquartered in San Mateo, California. The company has developed Project M (also marketed as EchoAI), a custom CNN-based platform that performs multimodal analysis of facial expressions, micro-expressions, tone of voice, and language to detect eight primary emotions across multiple intensity levels, claiming 95%+ ROC/AUC accuracy and a 96% emotional comprehension rate. The platform was trained over seven years on more than 500,000 labeled data points produced by nearly 500 collaborators contributing 130,000+ hours of emotional mapping.

The company distributes its technology through three commercial vectors: a freemium EchoAI Mobile App for individual consumers; the IEAI Interview Platform, an enterprise B2B SaaS product applying emotion AI to candidate assessment; and an FDA Class 1 SaMD-registered, HIPAA-compliant Telemedicine Platform that functions as a Clinical Decision Support System for remote patient emotional assessment (commercialized via partnerships such as BeWell Health). A social-impact sub-brand, EchoBloom Initiatives, runs donation-funded AI-assisted art therapy programs for neurodiverse individuals.

Revenue is sourced from mobile app subscriptions, enterprise licensing, telemedicine platform integration deals, and small-scale donations. The company has raised a disclosed $150,000 pre-seed round led by Jumpstart Foundry (2023), received an earlier Google grant (2019), and operates from a small founding team augmented by a university internship pipeline across nine partner institutions.

Short descriptiontext

IPMD, Inc. is a San Mateo-based emotional AI company that builds the EchoAI (Project M) multimodal CNN platform to detect facial micro-expressions and emotions for telemedicine, enterprise hiring, and consumer self-awareness applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSan Mateo, United States
HQ citystring
San Mateo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
emotional AI software, AI telemedicine platform, AI hiring analytics, facial recognition technology, micro-expression detection
Industry1 code
PRIMARYHDAAAFAI
Emotion, Sentiment & Paralinguistic Intelligence
NAICS code2 codes
  • Telephone Call Centers56142
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Emotional AI Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1EchoAI Mobile App Subscriptions
TypeFreemium
Description

Freemium model with free tier offering basic emotional status and mood status tracking. Premium tier provides comprehensive features including emotion frequency, emotion status frequency, emotion pairs, mood frequency, mood status frequency, and mood pairs analysis. Mobile app available for download.

ipmdinc.com
2IEAI Interview Platform (Enterprise Licensing)
TypeSubscription Recurring
Description

B2B SaaS platform for enterprise talent acquisition. Provides data-driven candidate assessment, emotion-based questioning, and comprehensive analytics for hiring decisions. Revenue from enterprise seat licenses or platform subscriptions.

ipmdinc.com
3Telemedicine Platform Licensing
TypeLicensing Royalties
Description

Integration of Emotional AI into healthcare systems as Medical Agentic AI. Revenue from partnerships with healthcare providers and telemedicine platforms. HIPAA-compliant, FDA Class 1 medical device registration (SaMD).

ipmdinc.com
4EchoBloom Donations
TypeSubscription Recurring
Description

Donation-based funding for EchoBloom Initiatives supporting neurodiverse artists and AI art therapy programs. Donation tiers starting at $5 with Digital Gallery access rewards. 40% to artists, 20% to AI R&D, 40% to operations.

ipmdinc.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1Free Tier - Basic emotional analysis
ModelFreemiumBilling cadenceMonthly
Notes

Free tier includes overall emotion status and overall mood status tracking. Available for download via mobile app.

ipmdinc.com
2Premium Tier - Comprehensive emotional insights
ModelSubscriptionBilling cadenceMonthly
Notes

Premium tier includes emotion frequency, emotion status frequency, emotion pairs, mood frequency, mood status frequency, mood pairs. Full emotional intelligence superpower access.

ipmdinc.com
3EchoBloom Donation Tiers
ModelSubscriptionBilling cadenceMonthly
Notes

Donation tiers at $1, $5, $50, $100, $500 levels with one-time, monthly, or yearly frequency options. Digital Gallery access provided as donor reward.

ipmdinc.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

IPMD develops and sells EchoAI, an emotional intelligence platform that uses proprietary CNN-based AI to detect micro-expressions and analyze eight primary emotions in real time across facial, vocal, and linguistic inputs. Its commercial offerings include a consumer-facing EchoAI Mobile App (freemium subscription), an IEAI Interview Platform for enterprise hiring, a Class 1 FDA-registered Telemedicine Platform that integrates emotional AI into virtual care workflows, and the EchoBloom Initiatives art therapy program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 96% emotional comprehension rate achieved through 130,000+ hours of training
+2 more records
Product overview1 text field

IPMD offers a platform-plus-modules architecture centered on EchoAI, its flagship emotional intelligence platform. The core Project M technology powers all offerings through advanced CNN-based facial micro-expression analysis achieving 95%+ accuracy. The EchoAI Mobile App extends these capabilities to consumers via mobile devices. Specialized modules include the IEAI Interview Platform for AI-powered talent acquisition and the Emotional AI Telemedicine Platform (Class 1 CDSS) for remote patient emotional assessment. EchoBloom Initiatives represents a social impact sub-brand focused on inclusive AI-supported art therapy for neurodiverse and trauma-affected individuals. The ecosystem is unified by shared emotional AI technology that analyzes facial expressions, voice, and language in real-time across all products.

Product and service6 records
1Project M (Emotional AI Platform)
CategoryEmotional AI Software / Core Platform
Description

Core emotional AI platform using advanced CNN-based algorithms to detect micro-expressions and analyze 8 primary emotions across multiple intensity levels, achieving over 95% ROC/AUC accuracy on 500,000+ labeled data points covering 400,000+ emotional variables.

2EchoAI Platform
CategoryEmotional AI Software / SaaS
Description

Flagship emotional intelligence platform evaluating users' emotional states through multimodal analysis of facial expressions, tone of voice, language, and micro-expressions, offering a 96% emotional comprehension rate with personalized empathy-driven responses as a digital mirror.

3EchoAI Mobile App
CategoryConsumer Mobile App
Description

Consumer-facing mobile application delivering EchoAI capabilities directly to individuals; users capture selfie videos through their mobile camera to receive real-time insights into their emotional state, enabling self-awareness and emotional intelligence development under a freemium model.

4IEAI Interview Platform
CategoryEnterprise HR / Hiring SaaS
Description

AI-powered hiring platform that uses facial emotional AI technology to assess candidate suitability beyond resumes and interviews; analyzes micro-expressions including joy, contempt, anger, and fear, with emotion-based adaptive questioning, candidate profile management, and data-driven hiring analytics for enterprise talent acquisition teams.

5Emotional AI Telemedicine Platform
CategoryHealthcare SaaS / Clinical Decision Support
Description

Class 1 CDSS (Clinical Decision Support System) and FDA-registered SaMD Class 1 medical device that integrates EchoAI into telemedicine workflows to help physicians understand patient emotional states during virtual consultations; provides real-time emotional analysis during video calls and exports comprehensive 24-hour post-session emotional analysis PDF reports, HIPAA-compliant.

6EchoBloom Initiatives
CategorySocial Impact / Art Therapy Program
Description

Creative and inclusive sub-brand program that combines individuals with disabilities, human artists, and Emotional AI to co-create transformative art for healing and dignity; supports AI-supported art therapy for participants with autism, intellectual and developmental disabilities, dementia, and trauma, funded through a donation-based model with Digital Gallery access rewards.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeTechnology or Integration
Description

Received Google funding to build a secure, scalable RESTful emotional AI API. Named a Google Cloud Build Partner ensuring scalable emotional AI development. Accepted into Google's GCP Surge Program empowering infrastructure with elite cloud tools.

Strategic tierCoreTypeTechnology or Integration
Description

Selected for NVIDIA's Inception Program gaining access to advanced AI mentorship and GPU acceleration. Invited to NVIDIA Capital Connect opening direct access to leading AI investors. Won Texas Children's Hospital Hackathon with emotional AI solution.

Strategic tierCoreTypeTechnology or Integration
Description

AWS Active Member supporting cloud-based scaling of EchoAI platform through AWS Activate program for startups.

Strategic tierCoreTypeTechnology or Integration
Description

IBM Startup Program member supporting development and technology infrastructure.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Selected among top 15 startups to compete at Silicon Valley Regional Finals on August 3, 2023 at the Computer History Museum.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Named Deep Tech Pioneers by Hello Tomorrow, a mission-driven global organization accelerating deep technologies to solve pressing societal changes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to integrate EchoAI into next-generation Medical Agentic AI for telehealth systems to assess emotional states alongside medical data.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

IPMD signed MOU with House of Grace for EchoBloom Initiatives supporting neurodiverse individuals through AI art therapy.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Won Touchless Experience Category of Texas Children's Hospital Healthcare Hackathon with Project M emotional AI solution for hospital environments.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

IPMD Internship Programs are qualified for university course credits including IB 99/199, MCB 99/199, STAT 199, Econ 197, PP199, Cog Sci 197, PH 297, DS 97/197, and CS 97/197.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Real-time emotional AI for call-center agent coaching, similar in combining voice + behavior analytics. Comparable to IPMD's emotional AI for enterprise customer interaction use cases.

TypeDirect peer
Description

Face recognition and emotion detection API provider. Comparable to IPMD's CNN-based facial emotion analysis sold as developer/enterprise APIs.

TypeOthers
Description

Conversational AI for enterprise procurement negotiations. Adjacent rather than direct, but illustrative of how AI-driven conversational/intelligence platforms are being productized for specific enterprise verticals in a similar go-to-market motion to IPMD's IEAI.

TypeDirect peer
Description

Emotion-AI platform measuring attention and emotion via webcam for advertising effectiveness and market research. Directly comparable to IPMD's facial emotion-recognition technology and consumer/enterprise data output.

TypeEmerging player
Description

Voice emotion AI (Japan-based) used for mental wellness and call-center monitoring. Adjacent technology overlap with IPMD's voice tone analysis component.

TypeDirect peer
Description

Voice- and expression-based emotional AI foundation models with a developer API. Comparable to EchoAI's multimodal (face + voice + language) emotion analysis and similar positioning as an emotion-AI platform for builders.

7Microsoft Azure Cognitive Services (Face API)
TypeBroad incumbent
Description

Hyperscaler emotion/face API that IPMD explicitly benchmarks against. Broader incumbent offering overlapping emotion-detection capability inside a much larger AI/cloud portfolio.

8Sensely
TypeDirect peer
Description

Virtual medical assistant with empathy/emotional intelligence for telemedicine triage. Comparable to IPMD's Emotional AI Telemedicine Platform as a clinical decision support product integrated into telehealth workflows.

TypeDirect peer
Description

Pioneer in facial emotion AI / affective computing, now part of Smart Eye. Closest direct competitor to IPMD's Project M / EchoAI in terms of multimodal emotion detection from video and similar enterprise/automotive customer base.

TypeEmerging player
Description

AI mental-health companion using conversational AI for emotional support. Adjacent to IPMD's telemedicine emotional-AI use case but focused on direct-to-consumer mental health rather than physician CDSS.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IPMD, Inc.

Emotional AI Softwareipmdinc.com

IPMD, Inc. is a San Mateo-based emotional AI company that builds the EchoAI (Project M) multimodal CNN platform to detect facial micro-expressions and emotions for telemedicine, enterprise hiring, and consumer self-awareness applications.

What IPMD, Inc. does

IPMD, Inc. is a privately held emotional AI company founded in 2016 and headquartered in San Mateo, California. The company has developed Project M (also marketed as EchoAI), a custom CNN-based platform that performs multimodal analysis of facial expressions, micro-expressions, tone of voice, and language to detect eight primary emotions across multiple intensity levels, claiming 95%+ ROC/AUC accuracy and a 96% emotional comprehension rate. The platform was trained over seven years on more than 500,000 labeled data points produced by nearly 500 collaborators contributing 130,000+ hours of emotional mapping.

The company distributes its technology through three commercial vectors: a freemium EchoAI Mobile App for individual consumers; the IEAI Interview Platform, an enterprise B2B SaaS product applying emotion AI to candidate assessment; and an FDA Class 1 SaMD-registered, HIPAA-compliant Telemedicine Platform that functions as a Clinical Decision Support System for remote patient emotional assessment (commercialized via partnerships such as BeWell Health). A social-impact sub-brand, EchoBloom Initiatives, runs donation-funded AI-assisted art therapy programs for neurodiverse individuals.

Revenue is sourced from mobile app subscriptions, enterprise licensing, telemedicine platform integration deals, and small-scale donations. The company has raised a disclosed $150,000 pre-seed round led by Jumpstart Foundry (2023), received an earlier Google grant (2019), and operates from a small founding team augmented by a university internship pipeline across nine partner institutions.

IPMD, Inc. firmographics

Firmographics
Name
IPMD, Inc.
Legal name
IPMD, Inc.
Website
https://ipmdinc.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
IPMD, Inc. is a San Mateo-based emotional AI company that builds the EchoAI (Project M) multimodal CNN platform to detect facial micro-expressions and emotions for telemedicine, enterprise hiring, and consumer self-awareness applications.
Ownership category
akta.pro rank

IPMD, Inc. industry classification

Industry
Product category
Emotional AI Software
NAICS
Telephone Call Centers (56142), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHDAAAFAI
Emotion, Sentiment & Paralinguistic Intelligence

Keywords

  • Emotional AI software
  • AI telemedicine platform
  • AI hiring analytics
  • Facial recognition technology
  • Micro-expression detection

Where IPMD, Inc. is headquartered

Location

Headquarters

HQ city
San Mateo
HQ country
United States
HQ region
North America

Offices2 records

Markets served

IPMD, Inc. business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. EchoAI Mobile App Subscriptions: Freemium model with free tier offering basic emotional status and mood status tracking. Premium tier provides comprehensive features including emotion frequency, emotion status frequency, emotion pairs, mood frequency, mood status frequency, and mood pairs analysis. Mobile app available for download.
  2. IEAI Interview Platform (Enterprise Licensing): B2B SaaS platform for enterprise talent acquisition. Provides data-driven candidate assessment, emotion-based questioning, and comprehensive analytics for hiring decisions. Revenue from enterprise seat licenses or platform subscriptions.
  3. Telemedicine Platform Licensing: Integration of Emotional AI into healthcare systems as Medical Agentic AI. Revenue from partnerships with healthcare providers and telemedicine platforms. HIPAA-compliant, FDA Class 1 medical device registration (SaMD).
  4. EchoBloom Donations: Donation-based funding for EchoBloom Initiatives supporting neurodiverse artists and AI art therapy programs. Donation tiers starting at $5 with Digital Gallery access rewards. 40% to artists, 20% to AI R&D, 40% to operations.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree Tier - Basic emotional analysis
SubscriptionMonthlyPremium Tier - Comprehensive emotional insights
SubscriptionMonthlyEchoBloom Donation Tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

IPMD, Inc. product offering

Product offering

Core offering

IPMD develops and sells EchoAI, an emotional intelligence platform that uses proprietary CNN-based AI to detect micro-expressions and analyze eight primary emotions in real time across facial, vocal, and linguistic inputs. Its commercial offerings include a consumer-facing EchoAI Mobile App (freemium subscription), an IEAI Interview Platform for enterprise hiring, a Class 1 FDA-registered Telemedicine Platform that integrates emotional AI into virtual care workflows, and the EchoBloom Initiatives art therapy program.

Product overview

IPMD offers a platform-plus-modules architecture centered on EchoAI, its flagship emotional intelligence platform. The core Project M technology powers all offerings through advanced CNN-based facial micro-expression analysis achieving 95%+ accuracy. The EchoAI Mobile App extends these capabilities to consumers via mobile devices. Specialized modules include the IEAI Interview Platform for AI-powered talent acquisition and the Emotional AI Telemedicine Platform (Class 1 CDSS) for remote patient emotional assessment. EchoBloom Initiatives represents a social impact sub-brand focused on inclusive AI-supported art therapy for neurodiverse and trauma-affected individuals. The ecosystem is unified by shared emotional AI technology that analyzes facial expressions, voice, and language in real-time across all products.

Differentiator

Problem solved

Functional benefit

Products and services

  • Project M (Emotional AI Platform) Core emotional AI platform using advanced CNN-based algorithms to detect micro-expressions and analyze 8 primary emotions across multiple intensity levels, achieving over 95% ROC/AUC accuracy on 500,000+ labeled data points covering 400,000+ emotional variables.
  • EchoAI Platform Flagship emotional intelligence platform evaluating users' emotional states through multimodal analysis of facial expressions, tone of voice, language, and micro-expressions, offering a 96% emotional comprehension rate with personalized empathy-driven responses as a digital mirror.
  • EchoAI Mobile App Consumer-facing mobile application delivering EchoAI capabilities directly to individuals; users capture selfie videos through their mobile camera to receive real-time insights into their emotional state, enabling self-awareness and emotional intelligence development under a freemium model.
  • IEAI Interview Platform AI-powered hiring platform that uses facial emotional AI technology to assess candidate suitability beyond resumes and interviews; analyzes micro-expressions including joy, contempt, anger, and fear, with emotion-based adaptive questioning, candidate profile management, and data-driven hiring analytics for enterprise talent acquisition teams.
  • Emotional AI Telemedicine Platform Class 1 CDSS (Clinical Decision Support System) and FDA-registered SaMD Class 1 medical device that integrates EchoAI into telemedicine workflows to help physicians understand patient emotional states during virtual consultations; provides real-time emotional analysis during video calls and exports comprehensive 24-hour post-session emotional analysis PDF reports, HIPAA-compliant.
  • EchoBloom Initiatives Creative and inclusive sub-brand program that combines individuals with disabilities, human artists, and Emotional AI to co-create transformative art for healing and dignity; supports AI-supported art therapy for participants with autism, intellectual and developmental disabilities, dementia, and trauma, funded through a donation-based model with Digital Gallery access rewards.

Quantifiable outcome

  • 96% emotional comprehension rate achieved through 130,000+ hours of training
  • +2 more outcomes

Companies that use IPMD, Inc.

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

IPMD, Inc. technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature6 records

IPMD, Inc. partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • Google (GCP, Cloud Build Partner)coreTechnology or IntegrationReceived Google funding to build a secure, scalable RESTful emotional AI API. Named a Google Cloud Build Partner ensuring scalable emotional AI development. Accepted into Google's GCP Surge Program empowering infrastructure with elite cloud tools.
  • NVIDIA (Inception Program, Capital Connect)coreTechnology or IntegrationSelected for NVIDIA's Inception Program gaining access to advanced AI mentorship and GPU acceleration. Invited to NVIDIA Capital Connect opening direct access to leading AI investors. Won Texas Children's Hospital Hackathon with emotional AI solution.
  • AWS ActivatecoreTechnology or IntegrationAWS Active Member supporting cloud-based scaling of EchoAI platform through AWS Activate program for startups.
  • IBM Startup ProgramcoreTechnology or IntegrationIBM Startup Program member supporting development and technology infrastructure.
  • Startup World CupcoreGTM or Marketing PartnerSelected among top 15 startups to compete at Silicon Valley Regional Finals on August 3, 2023 at the Computer History Museum.
  • Hello TomorrowcoreStrategic or Co-development PartnerNamed Deep Tech Pioneers by Hello Tomorrow, a mission-driven global organization accelerating deep technologies to solve pressing societal changes.
  • BeWell HealthcoreStrategic or Co-development PartnerPartnership to integrate EchoAI into next-generation Medical Agentic AI for telehealth systems to assess emotional states alongside medical data.
  • House of GracecoreStrategic or Co-development PartnerIPMD signed MOU with House of Grace for EchoBloom Initiatives supporting neurodiverse individuals through AI art therapy.
  • Texas Children's HospitalcoreStrategic or Co-development PartnerWon Touchless Experience Category of Texas Children's Hospital Healthcare Hackathon with Project M emotional AI solution for hospital environments.
  • University Partnerships (Waterloo, SJSU, ESADE, Columbia, NYU, Vanderbilt, UPenn, Juilliard, UC Berkeley)minorStrategic or Co-development PartnerIPMD Internship Programs are qualified for university course credits including IB 99/199, MCB 99/199, STAT 199, Econ 197, PP199, Cog Sci 197, PH 297, DS 97/197, and CS 97/197.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

IPMD, Inc. competitors and assessment

Company assessment

Direct peers

  • Cogito: Real-time emotional AI for call-center agent coaching, similar in combining voice + behavior analytics. Comparable to IPMD's emotional AI for enterprise customer interaction use cases.
  • Kairos: Face recognition and emotion detection API provider. Comparable to IPMD's CNN-based facial emotion analysis sold as developer/enterprise APIs.
  • Realeyes: Emotion-AI platform measuring attention and emotion via webcam for advertising effectiveness and market research. Directly comparable to IPMD's facial emotion-recognition technology and consumer/enterprise data output.
  • Hume AI: Voice- and expression-based emotional AI foundation models with a developer API. Comparable to EchoAI's multimodal (face + voice + language) emotion analysis and similar positioning as an emotion-AI platform for builders.
  • Sensely: Virtual medical assistant with empathy/emotional intelligence for telemedicine triage. Comparable to IPMD's Emotional AI Telemedicine Platform as a clinical decision support product integrated into telehealth workflows.
  • Affectiva (Smart Eye): Pioneer in facial emotion AI / affective computing, now part of Smart Eye. Closest direct competitor to IPMD's Project M / EchoAI in terms of multimodal emotion detection from video and similar enterprise/automotive customer base.

Others

  • Pactum AI: Conversational AI for enterprise procurement negotiations. Adjacent rather than direct, but illustrative of how AI-driven conversational/intelligence platforms are being productized for specific enterprise verticals in a similar go-to-market motion to IPMD's IEAI.

Emerging players

  • Empath: Voice emotion AI (Japan-based) used for mental wellness and call-center monitoring. Adjacent technology overlap with IPMD's voice tone analysis component.
  • Wysa: AI mental-health companion using conversational AI for emotional support. Adjacent to IPMD's telemedicine emotional-AI use case but focused on direct-to-consumer mental health rather than physician CDSS.

Broad incumbents

  • Microsoft Azure Cognitive Services (Face API): Hyperscaler emotion/face API that IPMD explicitly benchmarks against. Broader incumbent offering overlapping emotion-detection capability inside a much larger AI/cloud portfolio.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

IPMD, Inc. social profiles

Digital presence

IPMD, Inc. compliance and trust

Trust signal

Compliance2 records

IPMD, Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IPMD, Inc. leadership team

Management profile

Number of profiles

Profiles9 records

IPMD, Inc. funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IPMD, Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IPMD, Inc.

What does IPMD, Inc. do?

IPMD develops and sells EchoAI, an emotional intelligence platform that uses proprietary CNN-based AI to detect micro-expressions and analyze eight primary emotions in real time across facial, vocal, and linguistic inputs. Its commercial offerings include a consumer-facing EchoAI Mobile App (freemium subscription), an IEAI Interview Platform for enterprise hiring, a Class 1 FDA-registered Telemedicine Platform that integrates emotional AI into virtual care workflows, and the EchoBloom Initiatives art therapy program.

Is IPMD, Inc. a public or private company?

IPMD, Inc. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was IPMD, Inc. founded?

IPMD, Inc. was founded in 2016. It employs 51 to 100 people.

Where is IPMD, Inc. based?

IPMD, Inc. is headquartered in San Mateo, United States, in the North America region.

How does IPMD, Inc. make money?

Four revenue lines are on record. EchoAI Mobile App Subscriptions are the primary driver. The others are IEAI Interview Platform (Enterprise Licensing), telemedicine Platform Licensing and echoBloom Donations.

Who are IPMD, Inc.'s main competitors?

Direct peers on record are Cogito, Kairos, Realeyes, Hume AI, Sensely and Affectiva (Smart Eye). Pactum AI is listed as an others. Emerging players are Empath and Wysa. Microsoft Azure Cognitive Services (Face API) is listed as a broad incumbent.

Does IPMD, Inc. have an API?

Yes. IPMD received Google funding to build a secure, scalable RESTful emotional AI API. The API enables real-time video feed analysis for emotional state detection. EchoAI platform provides an Emotional AI virtual API calling capability for telemedicine applications.

What industry is IPMD, Inc. in?

IPMD, Inc.'s product category is Emotional AI Software. Its primary akta.pro industry code is HDAAAFAI, Emotion, Sentiment & Paralinguistic Intelligence. Its NAICS code is 56142 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogdynaCERT Expands into the Port Market: French Port Equips Crane Fleet with HydraGEN™dynaCERT Inc., a Canadian Cleantech company, has completed the first commercial port installation of its HydraGEN™ technology at the Port of Rochefort–Tonnay-Charente in France, equipping all five cranes in the fleet following a successful prototype trial in July 2025. The hydrogen-based electrolysis system, distributed in France through partner IPMD, reduces CO₂, nitrogen oxides, carbon monoxide, and particulate matter emissions by 20–45% while improving engine performance and extending maintenance intervals. The company is positioning this deployment as a strategic entry into the port and maritime infrastructure sector, targeting the estimated 64% of global port equipment that remains diesel-powered.PR NewswireMin Lee of IPMD Wins 2025 Business Worldwide Magazine CEO AwardMin Lee, CEO and Founder of IPMD, was named "Visionary CEO in Emotional AI & Human-Centered Healthcare Innovation" in Business Worldwide Magazine's 2025 CEO Awards for his work developing EchoAI, an emotional intelligence platform born from a personal tragedy in 2015. The platform, developed through over 130,000 hours of research with a reported 96% emotional comprehension rate, analyzes facial expressions, tone of voice, language and micro-expressions to provide real-time emotional analysis. IPMD is integrating EchoAI into healthcare through a partnership with BeWell Health and holds Google Technology Build Partner status for its Medical Agentic AI technology.Neuroscience NewsGood Sleep Habits Can Buffer Kids From Stress-Linked ImpulsivityA study of 11,858 children aged 9-10 found that less than nine hours of sleep or over 30 minutes to fall asleep linked to impulsive behaviors. Sleep mediated the effect of stressful environments on impulsivity, and sleep interventions could be a cost-efficient way to help children in stressful situations.Neuroscience NewsStress Hormone in Pregnancy Bolsters Child’s Early Language SkillsA study of 1,093 Danish women and children found that high prenatal cortisol levels in the third trimester boosted early language skills. Boys exposed to high cortisol said more words between 12-37 months, while girls understood more words at 12-21 months. Researchers plan to investigate links to IQ scores.Neuroscience NewsEmotionally Aware AI: ChatGPT Outshines Humans in Emotional TestsA study using the Level of Emotional Awareness Scale found ChatGPT outperformed the general population in emotional awareness, with a Z-score of 2.84 initially and 4.26 after one month. The AI's accuracy was 9.7 out of 10, suggesting potential for cognitive training and psychiatric diagnosis.Neuroscience NewsContext Matters: Oxytocin Influenced by Context of Social TouchResearchers at Linköping University and the University of Skövde found that oxytocin levels rise after a partner's touch but not after a stranger's, depending on who initiated. The study of 42 women showed oxytocin increased after partner touch, then fell, and rose again after stranger touch, but not when the stranger initiated first. The findings suggest context matters for synthetic oxytocin treatments.SciencedailyViewing art can improve our mood and well-beingA study of 240 participants viewing an interactive Monet exhibition online found significant mood and anxiety improvements after just a few minutes. The benefits were greater for individuals with high aesthetic responsiveness, suggesting online art viewing can support well-being, especially for those unable to visit museums in person.SciencedailyPreschoolers prefer to learn from a competent robot than an incompetent humanConcordia researchers found that five-year-olds preferred learning from a competent robot over an incompetent human, while three-year-olds showed no preference. The study, published in the Journal of Cognition and Development, is the first to compare a human speaker and a robot on children's trust. The findings suggest children value competency over social similarity when choosing a teacher.SciencedailyThe influence of AI on trust in human interactionResearchers at the University of Gothenburg examined how advanced AI systems affect trust in human interactions, finding that human-like AI voices make it harder to detect deception. They argue that AI should have clearly synthetic voices to increase transparency, as current designs may cause excessive suspicion and harm relationships.SciencedailyAI-equipped eyeglasses read silent speechCornell researchers developed EchoSpeech, wearable eyeglasses that use acoustic sensing and AI to recognize up to 31 silent commands from lip movements. The low-power system requires minutes of training data and runs on a smartphone, with about 95% accuracy. It could aid voice synthesizers for people who cannot vocalize.